Georgia Life Sciences Designates Augusta as Newest BioReady® Community

AUGUSTA, GA-May 15, 2025 – The City of Augusta has been designated a BioReady Gold Community by the state’s leading life sciences membership organization, Georgia Life Sciences. To receive this distinction, communities must meet certain criteria related to zoning practices and infrastructure capacity.

“We are proud to recognize the City of Augusta as our latest BioReady community. A hub for life sciences, boasting Augusta University's Health Sciences Campus, including the Medical College of Georgia, and companies like Manus, Augusta is known as the ‘City of Medicine,’” said Maria Thacker-Goethe, President and CEO of Georgia Life Sciences. “Through this program, we champion communities that have made a commitment to expanding access to resources and infrastructure, boosting commercialization.”

The BioReady rating system rates communities in three tiers from Bronze to Silver to Gold. Through these BioReady ratings, Georgia Life Sciences allows local municipalities to better showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify biotech-friendly sites more effectively, making them a desirable choice for real estate developers and biotechnology companies seeking destinations to locate. 

For more information about this recognition, visit the BioReady Communities website at https://www.galifesciences.org/resources/bioready-communities. 

< Older Post

Newer Post >

September GBG Report Now Available – Federal Funding Insights for Georgia Life Sciences Members

September 11, 2025

Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.

Advocating for U.S. Agricultural Biotechnology Leadership

By Maria Thacker Goethe • September 5, 2025

Protecting U.S. Leadership in Agricultural Biotechnology

2025 Georgia Life Sciences Summit Poster Session Winners

By Maria Thacker Goethe • August 29, 2025

Celebrating the Next Generation of Scientific Breakthroughs in Georgia

Georgia Life Sciences Designates Augusta as Newest BioReady® Community